BioSpace News Archive

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration issued an advisory on its dry eye syndrome Phase 3 clinical trial. To access the advisory, go to the following link: http://www.regenerx.com/2020-03-18-Ma

Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced the closing of an over $30 million Series E Preferred Stock financing round led by D1 Capital Partners. Proceeds will be used for continued clin

All the benefits of the industry leading BioFlux cell analysis platform, now in a configuration every lab can afford.

AXIM ® Biotechnologies, Inc. announced today that the Company has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). In January of this year, AXIM announced that the Company signed a binding term sheet to acquire Sapphire.

Legion Healthcare Partners is pleased to announce the addition of James Welsh, MD to its Scientific Advisory Board. Dr. Welsh is an Associate Professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center.

What’s New: Today, Intel announced the readiness of Pohoiki Springs, its latest and most powerful neuromorphic research system providing the computational capacity of 100 million neurons. The cloud-based system will be made available to members of the Intel Neuromorphic Research Community (INRC), extending their neuromorphic work to solve larger, more complex problems.

Prominence Advisors is excited to announce that they have partnered with Tableau to bring an industry-leading Perioperative Solution to the broader healthcare analytics space.

Expansion will help company meet surge in demand for private courier services, speeding delivery of prescription drugs to patients with complex medication needs

Protech Home Medical Corp. (the “Company” or “Protech”) (TSXV: PTQ), a healthcare services company with operations in the U.S., provides the following business update in the face of the Covid-19 pandemic.

ZOOM+Care has appointed a new Chief Growth Officer to its growing leadership team. Joining the company is Mike Payne, who previously served as an executive at Ancestry, Virta Health, and Omada Health..